Stifel analyst Chris O’Cull raised the firm’s price target on Cava Group (CAVA) to $175 from $118 and keeps a Buy rating on the ...

The plaintiffs in the $2.35 million award from last week, Douglas Muhlbauer and related entities, sued Stifel Nicolaus last ...

Stifel has downgraded Tempus AI (NASDAQ:TEM) to hold from buy, citing valuation and uncertainty about core growth in 2025.

Stifel Nicolaus analyst J. Parker Lane maintained a Hold rating on Shopify (SHOP – Research Report) today and set a price target of $115.00. The company’s shares closed yesterday at $108.92. According ...

U.S. inflation remains elevated based on the October CPI report released on Wednesday, complicating the outlook for the Federal Reserve's policy path, according to economists at Stifel, Nicolaus & Co.

Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences. Management plans to participate in the Stife ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

A lawyer in the case says his legal team was able to present text messages showing a Stifel wealth manager had been touting complex structured notes as low-risk investments.

Stifel has upgraded Orthofix Medical (NASDAQ:OFIX) to buy from hold, citing the company's new management, underappreciated ...

Reports indicate that Stifel analyst Erik Rasmussen raised his estimated valuation of the New Zealand rocket-maker by more ...

AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full ...

The Haskins Foundation announced Tuesday that Minnesota junior Isabella McCauley (Inver Grove, Heights, Minn.) was one of 25 ...